Latest News

Veryan Secures £18m Series B Funding.

January 2015.  Veryan Medical has announced a £18m series B funding round led by Imperial alongside co-investors Invesco Asset Management, Seroba Life Sciences and Seven Mile. This investment will be utilised to commercialise the BioMimics 3D stent in international markets and to fund an IDE study in pursuit of FDA approval for the device. The objective of Veryan’s...




Quanta Receives CE Mark for its Advanced Haemodialysis System SC+

Alcester, Warwickshire, UK, 6 January 2015: Quanta Fluid Solutions Ltd (“Quanta” or the “Company”), a pioneering developer of advanced haemodialysis systems, announces it has received CE mark for SC+, its portable, cartridge-based haemodialysis system. SC+ is designed to bring flexibility to dialysis patients and physicians by supporting all treatment regimens, from...


< back to home page